GSK3B and B-cell chronic lymphocytic leukemia: Thus, we analyzed the basal levels of N1-ICD and pS9-GSK3β, as a marker of GSK3β inactivation, in 30 CLL samples, and investigated whether there was a correlation between pS9-GSK3β levels and those of N1-ICD.